Literature DB >> 11274927

VAP-1: an adhesin and an enzyme.

M Salmi1, S Jalkanen.   

Abstract

Leukocyte extravasation from the blood into tissues is of paramount importance for normal immunosurveillance and in mounting adequate inflammatory responses. Multiple traditional adhesion molecules and chemoattractants on leukocytes and endothelial cells are involved in the emigration process. Vascular adhesion protein 1 (VAP-1) is a nonclassical inflammation-inducible endothelial molecule involved in leukocyte-subtype-specific rolling under physiological shear. Molecularly, VAP-1 belongs to a special class of cell surface amino oxidases. The enzymatic reaction itself and the biologically active end products can potentially regulate the adhesive status of the vessel wall. Thus, VAP-1 is an ectoenzyme that has inter-related adhesive and enzymatic functions in regulating physiological trafficking and inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274927     DOI: 10.1016/s1471-4906(01)01870-1

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  51 in total

1.  Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes.

Authors:  Marko Salmi; Craig Stolen; Pekka Jousilahti; Gennady G Yegutkin; Päivi Tapanainen; Tuula Janatuinen; Mikael Knip; Sirpa Jalkanen; Veikko Salomaa
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Gallium-labelled peptides for imaging of inflammation.

Authors:  Anne Roivainen; Sirpa Jalkanen; Cristina Nanni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

3.  Reversible inhibition of copper amine oxidase activity by channel-blocking ruthenium(II) and rhenium(I) molecular wires.

Authors:  Stephen M Contakes; Gregory A Juda; David B Langley; Nicholas W Halpern-Manners; Anthony P Duff; Alexander R Dunn; Harry B Gray; David M Dooley; J Mitchell Guss; Hans C Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

4.  (68)Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones.

Authors:  Petteri Lankinen; Tatu J Mäkinen; Tiina A Pöyhönen; Pauliina Virsu; Satu Salomäki; Antti J Hakanen; Sirpa Jalkanen; Hannu T Aro; Anne Roivainen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11-24       Impact factor: 9.236

Review 5.  Human copper-dependent amine oxidases.

Authors:  Joel Finney; Hee-Jung Moon; Trey Ronnebaum; Mason Lantz; Minae Mure
Journal:  Arch Biochem Biophys       Date:  2014-01-06       Impact factor: 4.013

6.  PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.

Authors:  Anu Autio; Tiina Ujula; Pauliina Luoto; Satu Salomäki; Sirpa Jalkanen; Anne Roivainen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-04       Impact factor: 9.236

7.  Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse.

Authors:  Marika Merinen; Heikki Irjala; Marko Salmi; Ilkka Jaakkola; Arno Hänninen; Sirpa Jalkanen
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.

Authors:  Shiho Yoshida; Miyuki Murata; Kousuke Noda; Takashi Matsuda; Michiyuki Saito; Wataru Saito; Atsuhiro Kanda; Susumu Ishida
Journal:  Jpn J Ophthalmol       Date:  2018-02-01       Impact factor: 2.447

9.  Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation.

Authors:  Serena Becchi; Alberto Buson; Jonathan Foot; Wolfgang Jarolimek; Bernard W Balleine
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

10.  Structural organization of mammalian copper-containing amine oxidase genes.

Authors:  H G Schwelberger
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.